NCT00433784View on ClinicalTrials.gov

H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to Clopidogrel

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

April 30, 2006

Conditions
Coronary Artery DiseaseElective Percutaneous Coronary Intervention
Interventions
DRUG

Clopidogrel

PROCEDURE

Blood sampling - platelet aggregation

PROCEDURE

Blood sampling - genotyping

Trial Locations (1)

H4J 1C5

Hôpital du Sacré-Coeur de Montréal, Montreal

All Listed Sponsors
lead

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

OTHER

NCT00433784 - H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to Clopidogrel | Biotech Hunter | Biotech Hunter